Depomed (DEPO) – Analyst Ratings
-
UPDATE: Janney Montgomery Scott Upgrades DepoMed Inc (DEPO) to Buy
-
Collegium Pharma (COLL): Low Upfront Payment Derisks Nucynta Deal, PT To $24 - Piper Jaffray
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to DEPO Stock Lookup